Going to Tri-Con Next Week?
If you are part of the diagnostics and drug discovery ecosystem, the Tri-Conference ranks as one of the must attend events of the year. The week-long event is scheduled to kick off this Sunday, February 19th, in beautiful San Francisco.
With a 24 year history of delivering molecular medicine and diagnostics breakthroughs and technologies, the International Molecular Med Tri-Conference will host 3,500+ drug discovery and development professionals from over 40 countries…a 20% increase in attendance over the past 5 years.
Consistent with our bench-to-bedside mission, Cancer Genetics, Inc. (CGI) is attending this prime event to meet with various partners, clients, and colleagues to discuss partnerships, biopharma clinical trial service projects, and IVD and CDx development opportunities.
Would you like to meet? If so, please drop me an email to arrange a meeting. See you there!
|CGI EXPERTS AT TRI-CON 2017
|Leslie Abad, MS|
|Sr Director, Biopharma Market Development & Collaborations|
|Rob Fannon, MPH, MBA|
|VP, Biopharma Solutions|
Anna Israyelyan, MD, PhD
Clinical Affairs Manager
Tel: 323.224.3900 x175